Exchange Traded Concepts’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Sell
2,625
-629
-19% -$157K ﹤0.01% 972
2025
Q4
$784K Sell
3,254
-491
-13% -$126K 0.01% 902
2025
Q3
$1.03M Buy
3,745
+933
+33% +$255K 0.01% 773
2025
Q2
$725K Buy
2,812
+283
+11% +$67.5K 0.01% 816
2025
Q1
$566K Buy
2,529
+2,016
+393% +$471K 0.01% 771
2024
Q4
$117K Buy
513
+26
+5% +$6.26K ﹤0.01% 1119
2024
Q3
$119K Buy
+487
New +$109K ﹤0.01% 1117
2024
Q1
Sell
-152
Closed -$26.1K 1396
2023
Q4
$26.1K Sell
152
-17
-10% -$2.61K ﹤0.01% 1035
2023
Q3
$25K Sell
169
-11,758
-99% -$2.13M ﹤0.01% 1117
2023
Q2
$2.61M Buy
11,927
+11,920
+170,286% +$2.66M 0.06% 235
2023
Q1
$1.53K Sell
7
-13,566
-100% -$2.94M ﹤0.01% 1118
2022
Q4
$2.82M Buy
13,573
+13,560
+104,308% +$2.98M 0.08% 161
2022
Q3
$3K Sell
13
-1,611
-99% -$367K ﹤0.01% 1122
2022
Q2
$340K Sell
1,624
-522
-24% -$111K 0.01% 675
2022
Q1
$520K Buy
2,146
+1,666
+347% +$403K 0.01% 632
2021
Q4
$125K Buy
480
+3
+0.6% +$778 ﹤0.01% 828
2021
Q3
$126K Buy
477
+443
+1,303% +$121K ﹤0.01% 756
2021
Q2
$8K Sell
34
-55
-62% -$11.6K ﹤0.01% 1068
2021
Q1
$17K Sell
89
-136
-60% -$27.3K ﹤0.01% 924
2020
Q4
$48K Sell
225
-54
-19% -$10.8K ﹤0.01% 743
2020
Q3
$48K Sell
279
-83
-23% -$15.3K ﹤0.01% 590
2020
Q2
$70K Buy
362
+16
+5% +$2.62K 0.01% 508
2020
Q1
$51K Buy
346
+286
+477% +$45.6K 0.03% 295
2019
Q4
$9K Buy
+60
New +$8.65K ﹤0.01% 315

Other funds holding RMD

Exchange Traded Concepts's RMD Position: Q1 2026 in Review

Exchange Traded Concepts reduced its ResMed (RMD) stake by 19% in Q1 2026, selling an estimated $157K and leaving 2,625 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Exchange Traded Concepts first reported a position in RMD in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.82M in Q4 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Exchange Traded Concepts held 2,625 shares of ResMed worth $589K as of Q1 2026.
  • Exchange Traded Concepts sold 629 ResMed shares in Q1 2026, an estimated $157K.
  • ResMed made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #972 holding.
  • Exchange Traded Concepts first reported a position in ResMed in Q4 2019 and has held it in 24 quarters since.
  • Exchange Traded Concepts's ResMed position peaked at $2.82M in Q4 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.